Zhonghong Pulin Medical Products Co., Ltd. (300981.SZ)
CNY 11.83
(-0.34%)
CNY 11.83
(-0.34%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.1 Billion CNY | 32.52% |
| 2022 | 1.57 Billion CNY | -67.97% |
| 2021 | 4.9 Billion CNY | 2.74% |
| 2020 | 4.77 Billion CNY | 308.13% |
| 2019 | 1.17 Billion CNY | 21.01% |
| 2018 | 967.53 Million CNY | 1.72% |
| 2017 | 951.15 Million CNY | 33.95% |
| 2016 | 710.08 Million CNY | 17.55% |
| 2015 | 604.08 Million CNY | 3.25% |
| 2014 | 585.04 Million CNY | 6.25% |
| 2013 | 550.61 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 603.51 Million CNY | 11.75% |
| 2024 Q1 | 540.08 Million CNY | 4.37% |
| 2024 Q3 | 689.83 Million CNY | 14.3% |
| 2023 Q3 | 582.86 Million CNY | 2.77% |
| 2023 FY | 2.08 Billion CNY | 32.52% |
| 2023 Q2 | 567.13 Million CNY | 31.36% |
| 2023 Q1 | 431.74 Million CNY | 22.7% |
| 2023 Q4 | 517.45 Million CNY | -11.22% |
| 2022 FY | 1.57 Billion CNY | -67.97% |
| 2022 Q4 | 351.87 Million CNY | 18.34% |
| 2022 Q3 | 297.33 Million CNY | -15.19% |
| 2022 Q2 | 350.6 Million CNY | -38.79% |
| 2022 Q1 | 572.75 Million CNY | -0.32% |
| 2021 Q1 | 2.27 Billion CNY | 23.7% |
| 2021 Q3 | 687.7 Million CNY | -49.93% |
| 2021 FY | 4.9 Billion CNY | 2.74% |
| 2021 Q2 | 1.37 Billion CNY | -39.58% |
| 2021 Q4 | 574.61 Million CNY | -16.44% |
| 2020 Q3 | 1.8 Billion CNY | 124.18% |
| 2020 Q2 | 805.18 Million CNY | 143.75% |
| 2020 FY | 4.77 Billion CNY | 308.13% |
| 2020 Q1 | 330.33 Million CNY | 16.39% |
| 2020 Q4 | 1.83 Billion CNY | 1.82% |
| 2019 Q4 | 283.83 Million CNY | 0.0% |
| 2019 FY | 1.17 Billion CNY | 21.01% |
| 2018 Q2 | 239.45 Million CNY | 0.0% |
| 2018 FY | 967.53 Million CNY | 1.72% |
| 2018 Q1 | 239.45 Million CNY | -7.27% |
| 2017 Q1 | 217.34 Million CNY | 7.45% |
| 2017 Q3 | 258.23 Million CNY | 18.81% |
| 2017 Q4 | 258.23 Million CNY | 0.0% |
| 2017 FY | 951.15 Million CNY | 33.95% |
| 2017 Q2 | 217.34 Million CNY | 0.0% |
| 2016 Q1 | 152.75 Million CNY | 4.56% |
| 2016 FY | 710.08 Million CNY | 17.55% |
| 2016 Q4 | 202.28 Million CNY | 0.0% |
| 2016 Q3 | 202.28 Million CNY | 32.42% |
| 2016 Q2 | 152.75 Million CNY | 0.0% |
| 2015 Q4 | 146.09 Million CNY | -0.0% |
| 2015 Q1 | 155.94 Million CNY | -2.1% |
| 2015 FY | 604.08 Million CNY | 3.25% |
| 2015 Q2 | 155.94 Million CNY | 0.0% |
| 2015 Q3 | 146.09 Million CNY | -6.32% |
| 2014 Q1 | 140.13 Million CNY | 0.0% |
| 2014 Q4 | 159.29 Million CNY | 0.0% |
| 2014 FY | 585.04 Million CNY | 6.25% |
| 2014 Q3 | 159.29 Million CNY | 13.67% |
| 2014 Q2 | 140.13 Million CNY | 0.0% |
| 2013 FY | 550.61 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 7.89 Billion CNY | 73.319% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 3.36 Billion CNY | 37.443% |
| Blue Sail Medical Co.,Ltd. | 4.92 Billion CNY | 57.272% |
| Andon Health Co., Ltd. | 3.18 Billion CNY | 33.93% |
| Allmed Medical Products Co., Ltd | 2.75 Billion CNY | 23.631% |
| Improve Medical Instruments Co., Ltd. | 644.62 Million CNY | -226.587% |
| Tofflon Science and Technology Group Co., Ltd. | 5.64 Billion CNY | 62.684% |
| Truking Technology Limited | 6.8 Billion CNY | 69.059% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 1.3 Billion CNY | -61.935% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 1.46 Billion CNY | -43.451% |
| Autek China Inc. | 1.73 Billion CNY | -21.189% |
| Intco Medical Technology Co., Ltd. | 6.91 Billion CNY | 69.572% |
| Jiangsu Apon Medical Technology Co., Ltd. | 417.98 Million CNY | -403.671% |
| Winner Medical Co., Ltd. | 8.18 Billion CNY | 74.279% |
| Imeik Technology Development Co.,Ltd. | 2.85 Billion CNY | 26.235% |
| Caina Technology Co., Ltd. | 410.47 Million CNY | -412.887% |